Home » Authors » Rainer B. Langen

Articles by Rainer B. Langen

Schering To Purchase Collateral For $140M In Stock Exchange

March 27, 2002

By Rainer B. Langen

Paion, Millennium Cooperate In Development Of MLN519

March 20, 2002

By Rainer B. Langen

Co.don Starts Phase III Trials Of DISC In Herniated Discs

March 20, 2002

By Rainer B. Langen

LION Streamlining Operations, Eliminating About 80 Positions

Feb. 20, 2002

By Rainer B. Langen

German Officials Compromise In Embryonic Stem Cell Debate

Feb. 6, 2002

By Rainer B. Langen

BioVisioN Raises EUR15M To Progress Programs In Peptides

Feb. 6, 2002

By Rainer B. Langen

Biogen Paying Schering $20M Or More Over MS Drug Patents

Jan. 30, 2002

By Rainer B. Langen

Merck KGaA Says Development Of ImClone Drug Stays On Track

Jan. 25, 2002

By Rainer B. Langen

Estonia Expects Gene Project To Help Health, Economy; Latvia Next

Jan. 23, 2002

By Rainer B. Langen

LION Acquiring NetGenics In Stock Deal Valued At US$17M

Jan. 23, 2002

By Rainer B. Langen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...